The VEGFR inhibitor cediranib improves the efficacy of fractionated radiotherapy in a colorectal cancer xenograft model

Melsens, ElodieElodieMelsensVerberckmoes, BertBertVerberckmoesRosseel, NatachaNatachaRosseelVanhove, ChristianChristianVanhoveDescamps, BenedicteBenedicteDescampsPattyn, PietPietPattynCeelen, WimWimCeelen2021-10-242021-10-2420171421-9921https://imec-publications.be/handle/20.500.12860/28961The VEGFR inhibitor cediranib improves the efficacy of fractionated radiotherapy in a colorectal cancer xenograft modelJournal articlehttps://www.karger.com/Article/Abstract/452741